
Asceneuron
Developer of therapeutic compounds designed to treat neurodegenerative disorders. The company focuses on developing treatments for a wide range of neurodegenerative diseases, including orphan tauopath...
Valuation
$0
Share Price
N/A
Total Raised
$138.1M
Last Round
N/A